Stryker price target raised to $375 from $360 at Piper Sandler

Piper Sandler analyst Matt O’Brien raised the firm’s price target on Stryker to $375 from $360 and keeps an Overweight rating on the shares. The firm notes Stryker reported Q4 results and guided for 2024 as well, both ahead of Street expectations. Piper admittedly was worried about its ability to deliver with such challenging comparable sales in Q4, but those concerns were misplaced.